The risk-based approach for evaluating newly obtained HBM data is challenging and requires information on relationships between biomarker concentrations and mycotoxin intake from human and/or animal studies or toxicokinetic modelling, as well as toxicity profiles including mode of action
In-Clinic Only (Arcadia, CA) Here is a breakdown of the costs for related wellness injections
PDP treats them as anecdotal information rather than proof of when KLOW starts working
Its concentration in plasma declines significantly with age from approximately 200 ng/mL at age 20 to roughly 80 ng/mL by age 60
To talk to a member of our team or schedule a consultation over the phone, please call our Beorne office at (830) 515-5193 or our McAllen office at (956) 969-8369
Although a significant lowering of serum p-CS and p-cresol glucuronide concentrations was not observed, the authors reported an apparent downward decline in the treated rats (Dong et al., 2024)